Form 8-K - Current report:
SEC Accession No. 0000950170-25-003832
Filing Date
2025-01-10
Accepted
2025-01-10 08:36:20
Documents
28
Period of Report
2025-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fdmt-20250110.htm   iXBRL 8-K 86948
2 EX-99.1 fdmt-ex99_1.htm EX-99.1 19398
3 GRAPHIC fdmt-ex99_1s1.jpg GRAPHIC 178813
4 GRAPHIC fdmt-ex99_1s2.jpg GRAPHIC 482955
5 GRAPHIC fdmt-ex99_1s3.jpg GRAPHIC 483048
6 GRAPHIC fdmt-ex99_1s4.jpg GRAPHIC 388365
7 GRAPHIC fdmt-ex99_1s5.jpg GRAPHIC 471603
8 GRAPHIC fdmt-ex99_1s6.jpg GRAPHIC 305389
9 GRAPHIC fdmt-ex99_1s7.jpg GRAPHIC 343194
10 GRAPHIC fdmt-ex99_1s8.jpg GRAPHIC 229310
11 GRAPHIC fdmt-ex99_1s9.jpg GRAPHIC 416712
12 GRAPHIC fdmt-ex99_1s10.jpg GRAPHIC 305878
13 GRAPHIC fdmt-ex99_1s11.jpg GRAPHIC 385389
14 GRAPHIC fdmt-ex99_1s12.jpg GRAPHIC 302109
15 GRAPHIC fdmt-ex99_1s13.jpg GRAPHIC 390208
16 GRAPHIC fdmt-ex99_1s14.jpg GRAPHIC 483084
17 GRAPHIC fdmt-ex99_1s15.jpg GRAPHIC 157171
18 GRAPHIC fdmt-ex99_1s16.jpg GRAPHIC 472738
  Complete submission text file 0000950170-25-003832.txt   8214883

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fdmt-20250110.xsd EX-101.SCH 24937
30 EXTRACTED XBRL INSTANCE DOCUMENT fdmt-20250110_htm.xml XML 4712
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39782 | Film No.: 25520608
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)